Order Article Reprints

Gal J, Milano G, Brest P, Ebran N, Gilhodes J, Llorca L, Dubot C, Romieu G, Desmoulins I, Brain E, et al. VEGF-Related Germinal Polymorphisms May Identify a Subgroup of Breast Cancer Patients with Favorable Outcome under Bevacizumab-Based Therapy—A Message from COMET, a French Unicancer Multicentric Study. Pharmaceuticals. 2020; 13(11):414. https://doi.org/10.3390/ph13110414

Gal, Jocelyn, Gérard Milano, Patrick Brest, Nathalie Ebran, Julia Gilhodes, Laurence Llorca, Coraline Dubot, Gilles Romieu, Isabelle Desmoulins, Etienne Brain, and et al. 2020. "VEGF-Related Germinal Polymorphisms May Identify a Subgroup of Breast Cancer Patients with Favorable Outcome under Bevacizumab-Based Therapy—A Message from COMET, a French Unicancer Multicentric Study" Pharmaceuticals 13, no. 11: 414. https://doi.org/10.3390/ph13110414

Gal, J., Milano, G., Brest, P., Ebran, N., Gilhodes, J., Llorca, L., Dubot, C., Romieu, G., Desmoulins, I., Brain, E., Goncalves, A., Ferrero, J.-M., Cottu, P.-H., Debled, M., Tredan, O., Chamorey, E., Merlano, M. C., Lemonnier, J., Etienne-Grimaldi, M.-C., & Pierga, J.-Y. (2020). VEGF-Related Germinal Polymorphisms May Identify a Subgroup of Breast Cancer Patients with Favorable Outcome under Bevacizumab-Based Therapy—A Message from COMET, a French Unicancer Multicentric Study. Pharmaceuticals, 13(11), 414. https://doi.org/10.3390/ph13110414